- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Nov 8, 2024)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Nov 8, 2024 | T-1624-17 | TMC | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 1 h |
| Nov 8, 2024 | T-2585-24 | CMC | Amgen Canada Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Carfilzomib*) | Toronto | 30 m |
| Nov 12, 2024 | T-1387-24 | CMC | Aralez Pharmaceuticals Canada Inc. V. Jamp Pharma Corporation Et Al. (Patent - Diclofenac*) | Toronto | 1 h |
| Nov 12, 2024 | T-1429-21 | T | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 5 d |
| Nov 12, 2024 | T-1608-24 | CMC | Aralez Pharmaceuticals Canada Inc. V. Jamp Pharma Corporation And Al (Patent - Diclofenac*) | Toronto | 1 h |
| Nov 12, 2024 | T-206-21 | TMC | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 1 h |
| Nov 13, 2024 | T-1506-20 | MED | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Toronto | 1 d |
| Nov 13, 2024 | T-2405-23 | M | Bailey Metal Products Limited V. Dcm Metal Corp. (Patent) | Toronto | 3 h |
| Nov 13, 2024 | T-1256-21 | CMC | Sony Music Entertainment Canada Inc. V. Suva Beauty Inc. Et Al (Copyright) | Toronto | 30 m |
| Nov 14, 2024 | T-1184-21 | M | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 4 h |
| Nov 14, 2024 | T-47-24 | M | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| Nov 14, 2024 | T-48-24 | M | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Nov 12, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 5 d |
| Nov 25, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 4 d |
| Nov 26, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 1 d |
| Dec 2, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 3 d |
| Dec 2, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 9 d |
| Dec 13, 2024 | T-206-21 | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 1 d |
| Dec 18, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | Toronto | 2 d |
| Jan 20, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 15 d |
| Jan 20, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 27, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Winnipeg | 8 d |
| Feb 10, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Ottawa | 1 d |
| Feb 13, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 13, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 17, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Mar 3, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 8 d |
| Mar 17, 2025 | T-1726-21 | 2660722 Ontario Inc. Et Al. V. Pacific Smoke International Inc. Et Al. (unknown) | Toronto | 10 d |
| Mar 20, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 d |
| Apr 28, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Toronto | 15 d |
| Apr 28, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 21 d |
| Apr 28, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 9 d |
| May 15, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| May 15, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 1 d |
| May 21, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Toronto | 3 d |
| May 26, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 10 d |
| May 26, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 10 d |
| Jun 2, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 3 d |
| Jun 11, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 2 d |
| Jun 12, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 d |
| Jun 23, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 14 d |
| Jul 16, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 2 d |
| Jul 22, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Jul 22, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Aug 11, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 8 d |
| Aug 18, 2025 | T-1917-23 | Bayer Inc And Regeneron Pharmaceuticals, Inc V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 18, 2025 | T-1918-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 10 d |
| Aug 25, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Sep 2, 2025 | T-1917-23 | Bayer Inc And Regeneron Pharmaceuticals, Inc V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1918-23 | Bayer Inc Et Al., V. Amgen Canada Inc (Patent) | Toronto | 2 d |
| Sep 8, 2025 | T-351-24 | Aralez Pharmaceuticals Canada Inc. V. Taro Pharmaceuticals Inc. Et Al. (Patent) | To be determined (TrialJA) | 5 d |
| Sep 15, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| Sep 19, 2025 | T-351-24 | Aralez Pharmaceuticals Canada Inc. V. Taro Pharmaceuticals Inc. Et Al. (Patent) | To be determined (TrialJA) | 1 d |
| Sep 22, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 22, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Oct 6, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 6, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 20, 2025 | T-886-21 | The Toronto-dominion Bank V. Thomas John Dyas Et Al (Trademark) | Toronto | 5 d |
| Oct 27, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2025 | T-1779-23 | Samsung Bioepis Co., Ltd V. Alexion Pharmaceuticals, Inc. (Copyright) | Toronto | 28 d |
| Nov 12, 2025 | T-1584-23 | Amgen Canada Inc. V. Alexion Pharmaceuticals, Inc. (Patent) | Toronto | 28 d |
| Nov 12, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 2 d |
| Nov 12, 2025 | T-296-24 | Bayer Inc. Et Al. V. Natco Pharma (canada) Inc. Et Al. (Patent) | Ottawa | 11 d |
| Nov 17, 2025 | T-2148-23 | Outsuka Pharmaceutical Co. Ltd. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Nov 24, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 8 d |
| Nov 24, 2025 | T-938-24 | Viiv Healthcare Company Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 12 d |
| Nov 27, 2025 | T-297-24 | Bayer Inc. Et Al V. Natco Pharma (canada) Inc. Et Al (Patent) | Ottawa | 12 d |
| Dec 1, 2025 | T-675-24 | Pfizer Canada Ulc Et Al. V. Glenmark Pharmaceuticals Canada Inc. Et Al. (Patent) | To be determined (TrialJA) | 10 d |
| Dec 8, 2025 | T-91-20 | University Of Saskatchewan Et Al. V. Newagco Inc. Et Al. (Patent) | Toronto | 2 d |
| Dec 15, 2025 | T-938-24 | Viiv Healthcare Company Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 3 d |
| Jan 7, 2026 | T-745-24 | Viiv Healthcare Company Et Al V. Sandoz Canada Inc. (Patent) | Toronto | 8 d |
| Jan 19, 2026 | T-2405-23 | Bailey Metal Products Limited V. Dcm Metal Corp. (Patent) | Toronto | 5 d |
| Jan 19, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 10 d |
| Jan 22, 2026 | T-745-24 | Viiv Healthcare Company Et Al V. Sandoz Canada Inc. (Patent) | Toronto | 2 d |
| Jan 28, 2026 | T-2405-23 | Bailey Metal Products Limited V. Dcm Metal Corp. (Patent) | Toronto | 1 d |
| Feb 2, 2026 | T-1322-24 | Hoffmann-la Roche Limited Et Al. V. Dr. Reddy's Laboratories Sa (Patent - Rituximab*) | To be determined (TrialJA) | 8 d |
| Feb 5, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 2 d |
| Feb 16, 2026 | T-1322-24 | Hoffmann-la Roche Limited Et Al. V. Dr. Reddy's Laboratories Sa (Patent - Rituximab*) | To be determined (TrialJA) | 2 d |
| Mar 2, 2026 | T-1583-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 8 d |
| Mar 2, 2026 | T-1584-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 8 d |
| Mar 16, 2026 | T-1321-24 | Lundbeck Canada Inc. Et Al. V. Jamp Pharma Corporation (Patent - Vortioxetine*) | To be determined (TrialJA) | 8 d |
| Mar 16, 2026 | T-1583-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Mar 16, 2026 | T-1584-24 | Novartis Pharmaceuticals Canada Inc. V. Apotex Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Mar 23, 2026 | T-1662-24 | Eisai Limited And Eisai R&d Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent - Lenvatinib*) | Toronto | 8 d |
| Mar 30, 2026 | T-1321-24 | Lundbeck Canada Inc. Et Al. V. Jamp Pharma Corporation (Patent - Vortioxetine*) | To be determined (TrialJA) | 2 d |
| Apr 15, 2026 | T-1662-24 | Eisai Limited And Eisai R&d Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent - Lenvatinib*) | Toronto | 2 d |
| Apr 27, 2026 | T-1770-24 | Novartis Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Nilotinib*) | To be determined (TrialJA) | 6 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Dec 10, 2024 | T-939-24 | Limbic Media Corporation V. Lutron Electronics Co., Inc. | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 3 h |
| Dec 16, 2024 | T-4-24 | The University Of British Columbia V Sage Dining Services Inc | Trade Mark Opposition | Vancouver | 1 d |
| Jan 9, 2025 | T-831-23 | Michal Chwaja V. 0710674 Bc Ltd. Dba Cottonmouth | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 3 h |
| Jan 14, 2025 | T-2576-22 | Victoria Compost And Conservation Education Society Et Al. V. Marika Smith | Copyright - Correction of Register | Vancouver | 2 h |
| Feb 6, 2025 | T-624-24 | G6 Hospitality Ip Llc V. Sandals Resorts International 2000 Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Mar 31, 2025 | T-28-24 | Grc Food Services Ltd. V. Chocoladefabriken Lindt & Sprungli Ag | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| Oct 9, 2024 | A-249-22 | Double Diamond Distribution Ltd. V. Crocs Canada, Inc. Et Al | Appeal (S.27 - Final) - Others [from T-1662-17 - Trade Mark Infringement] | Ottawa |
| Oct 9, 2024 | A-322-23 | Socan V. Siriusxm Canada Inc. | S.28 Copyright Board | Toronto |
| Oct 29, 2024 | A-189-23 | Voltage Pictures, Llc Et Al. V. Robert Salna Et Al. | Appeal (S.27 - Final) - Copyright Act [from T-662-16 - Copyright Infringement [Applications]] | Toronto |
| Nov 6, 2024 | A-290-23 | Jeff Toth Et Al V. Minister Of Mental Health And Addictions Et Al - Psilocybin* | Appeal (S.27 - Final) - Application for Judicial Review [from T-1424-22 - S. 18.1 Application for Judicial Review] | Ottawa |
| Nov 7, 2024 | A-61-24 | Galderma Canada Inc. V. Attorney General Of Canada | Appeal (S.27 - Final) - Application for Judicial Review [from T-906-20 - S. 18.1 Application for Judicial Review] | Toronto |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.